Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

[Targeted therapies in digestive oncology].

Boutayeb S, Bensouda Y, Fadoulkhair Z, Bakkraoui K, Bachouchi M, Errihani H.

Pathol Biol (Paris). 2012 Aug;60(4):264-8. doi: 10.1016/j.patbio.2012.05.013. Epub 2012 Jun 26. Review. French.

PMID:
22743093
2.

[Targeted therapies in digestive oncology].

Amram ML, Benamran DA, Roth AD.

Rev Med Suisse. 2011 May 25;7(296):1131-2, 1134-6. French.

PMID:
21721202
3.

[An new generation of antineoplastic agents--targeted therapy in gastrointestinal tumors].

Lang A, Graeven U.

Zentralbl Chir. 2009 Jun;134(3):189-92. doi: 10.1055/s-0029-1224838. Epub 2009 Jun 18. German. No abstract available.

PMID:
19544236
4.

[Antineoplastic chemotherapy of digestive tumors].

Espinosa Arranz E, Ordóñez Gallego A, González Barón M.

Med Clin (Barc). 1991 Mar 30;96(12):471-4. Review. Spanish. No abstract available.

PMID:
2056788
5.

[News in digestive oncology].

Michel P, Di Fiore F.

Bull Cancer. 2008 Jan;95(1):117-20. doi: 10.1684/bdc.2008.0573. French.

6.

Targeted therapies in the treatment of gastric cancer.

Ngeow J, Tan IB, Choo SP.

Asia Pac J Clin Oncol. 2011 Sep;7(3):224-35. doi: 10.1111/j.1743-7563.2011.01407.x. Review.

PMID:
21884434
7.

[Molecular targeted therapy for gastric cancer].

Muto O, Sakata Y.

Nihon Rinsho. 2012 Nov;70 Suppl 8:447-51. Japanese. No abstract available.

PMID:
23513882
8.

Esophagogastric cancer: integration of targeted therapies into systemic chemotherapy.

Moehler M, Schwarz S, Wagner AD.

Curr Cancer Drug Targets. 2011 Jul;11(6):681-7. Review.

PMID:
21651462
9.
11.

Anti-angiogenic strategies in gastrointestinal malignancies.

Whisenant J, Bergsland E.

Curr Treat Options Oncol. 2005 Sep;6(5):411-21. Review.

PMID:
16107244
12.

Chemosensitivity test for carcinoma of digestive organs.

Maehara Y, Kohnoe S, Sugimachi K.

Semin Surg Oncol. 1990;6(1):42-7.

PMID:
2154026
13.
14.

Novel approaches to target pancreatic cancer.

Porzner M, Seufferlein T.

Curr Cancer Drug Targets. 2011 Jul;11(6):698-713. Review.

PMID:
21599630
15.

Development of new drug strategies in infrequent digestive tumors: esophageal, biliary tract, and anal cancers.

Capdevila J, Ramos FJ, Macarulla T, Elez E, Ruiz-Echarri M, Perez-Garcia J, Tabernero J.

Curr Opin Oncol. 2009 Jul;21(4):374-80. doi: 10.1097/CCO.0b013e32832c9464. Review.

PMID:
19412097
16.

[Targeted therapies in colorectal cancer].

Sablin MP, Dreyer C, Colichi C, Bouattour M, Faivre S.

Rev Prat. 2010 Oct 20;60(8):1094-9. French.

PMID:
21197741
17.

[Targeted therapy in locally and metastatic recurrent cervical cancers].

Geiss R, De La Motte Rouge T, Dubot C, Leary A, Lhommé C, Pautier P, Scholl S, Rodrigues MJ.

Bull Cancer. 2014 Jul-Aug;101(7-8):748-55. doi: 10.1684/bdc.2014.1949. Review. French.

PMID:
25091657
18.

EO9 phase II study in advanced breast, gastric, pancreatic and colorectal carcinoma by the EORTC Early Clinical Studies Group.

Dirix LY, Tonnesen F, Cassidy J, Epelbaum R, ten Bokkel Huinink WW, Pavlidis N, Sorio R, Gamucci T, Wolff I, Te Velde A, Lan J, Verweij J.

Eur J Cancer. 1996 Oct;32A(11):2019-22.

PMID:
8943690
19.

Epidermal growth factor receptor (EGFR) inhibitors in gastrointestinal cancer.

Macarulla T, Casado E, Ramos FJ, Valverde C, Tabernero J.

Onkologie. 2006 Mar;29(3):99-105. Epub 2006 Mar 3. Review.

PMID:
16514271
20.

Targeted therapies in solid tumours: results and promises.

Pantaleo MA, Saponara M, Nannini M, Biasco G.

Minerva Med. 2007 Oct;98(5):603-23. Review. English, Italian.

PMID:
18043567

Supplemental Content

Support Center